In this video, Peter N. Schlegel, MD, FACS, discusses new updates to the male infertility clinical guideline, as presented at the 2021 American Urological Association Annual Meeting. Updates involve varicoceles, correcting lifestyle issues, clomiphene, and management of men with cancer. Schlegel is a professor of urology and reproductive medicine at Weill Cornell Medicine, New York, New York.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.